ECRI Institute's 2016 watch list includes device security and wearable sensors
ECRI Institute has released its annual list of the new and emerging drugs, devices, procedures and care processes most likely to impact patient care over the next 12-18 months.
Top 10 Hospital C-suite Watch List includes actionable recommendations for each entry.
“Taking an evidence-based, ‘just the facts’ approach to assessing new healthcare innovations—from gadgets to drugs to infrastructure issues—that have been on our radar for the last year, we present hospital leaders with unbiased guidance to support informed decision making and help them understand how new innovations will affect care delivery,” says Diane C. Robertson, director of ECRI Institute's health technology assessment.
- Mobile Stroke Units
- Medical Device Cybersecurity
- Wireless Wearable Sensors
- Miniature Leadless Pacemakers
- Blue-violet LED Light Fixtures
- New High-cost Cardiovascular Drugs
- Changing Landscape of Robotic Surgery
- Spectral Computed Tomography
- Injected Bioabsorbable Hydrogel (SpaceOAR®)
- Warm Donor Organ Perfusion Systems
“Hospital leaders have to deal with a lot of new technology issues—and demands from different departments in their facilities—so this list is intended to assist them in their efforts to update or implement their strategic technology plans,” said Robert P. Maliff, director of ECRI Institute's applied solutions group.
Editor
Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.